دارو جابرابن حیان
دجابر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 57,940 3.00
Close Price: 57,940
Financial Ratios
AGM
Interim
2026/04/19 Fiscal Year 2025/12/2112 Month | 2025/02/18 Fiscal Year 2024/12/2012 Month | 2024/03/16 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 8.93 | 65.67 | 15.21 | |
Gross Profit to Sales | 9.11 | 65.67 | 17.01 | |
Operating Margin | 12.18 | 7.11 | 17.71 | |
Gross Profit to Sales | 29.96 | 20.18 | 27.05 | |
Net Profit to Gross Profit | 29.81 | 325.47 | 56.24 | |
Return on Assets (ROA) | 5.41 | 31.54 | 8.16 | |
Return on Capital (%) | 62.72 | 364.93 | 71.33 | |
Return on Equity (ROE) | 12.05 | 59.55 | 23.94 | |
Working Capital Return | 13.2 | 67.03 | 36.43 | |
Fixed Asset Return | 77.55 | 426.26 | 87.89 | |
Loan Benefit Assessment | 2.23 | 1.89 | 2.93 | |
Current Ratio | 1.83 | 2.08 | 1.35 | |
Quick Ratio | 1.63 | 1.89 | 1.22 | |
Liquidity Ratio | 0.04 | 0.45 | 0.03 | |
Net Working Capital | 10,777,457 | 12,348,222 | 4,440,262 | |
Current Assets Ratio | 0.91 | 0.91 | 0.86 | |
Inventory Turnover | 77.26 | 70.06 | 90.47 | |
Receivables Collection Period | 432.93 | 460.63 | 451.18 | |
Inventory to Working Capital | 0.24 | 0.17 | 0.38 | |
Working Capital Turnover | 1.48 | 1.02 | 2.4 | |
Fixed Asset Turnover | 8.68 | 6.49 | 5.78 | |
Total Asset Turnover | 0.61 | 0.48 | 0.54 | |
Debt Ratio | 0.55 | 0.47 | 0.66 | |
Debt to Equity | 1.23 | 0.89 | 1.93 | |
Long-Term Debt to Equity | 0.12 | 0.07 | 0.07 | |
Current Debt to Equity | 1.1 | 0.82 | 1.86 | |
Equity Ratio | 44.91 | 52.97 | 34.08 | |
Debt Coverage Ratio | 1.26 | 2.08 | 3.9 |
